DIS vs MRK: Which Is the Better Buy?
Side-by-side comparison of The Walt Disney Company and Merck & Co., Inc. — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-07-10.
The Walt Disney Company · Communication Services
$96.16
+45.0% upside to fair value
Grade B
VS
Merck & Co., Inc. · Healthcare
$113.87
-12.1% upside to fair value
Grade D
High Quality
QuantHub Verdict
DIS has more upside to fair value
(+45.0%).
DIS trades at a lower forward P/E
(15.4x).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
DIS |
MRK |
| Current Price |
$96.16 |
$113.87 |
| Fair Value Estimate |
$139.43 |
$100.14 |
| Upside to Fair Value |
+45.0%
|
-12.1%
|
| Market Cap |
$167.0B |
$281.2B |
| Forward P/E |
15.4x
|
32.0x
|
| EV / EBITDA |
10.8x
|
17.3x
|
| Price / Sales |
1.7x
|
4.3x
|
| Price / FCF |
23.5x
|
19.9x
|
| Revenue Growth YoY |
+6.5%
|
+4.3%
|
| Gross Margin |
37.2%
|
75.9%
|
| Operating Margin |
15.5%
|
27.6%
|
| Return on Equity |
10.3%
|
17.9%
|
| Dividend Yield |
0% |
0% |
| FCF Yield |
4.26%
|
5.02%
|
| Analyst Consensus |
Strong Buy
|
Hold
|
Investment Thesis
The Walt Disney Company operates as a leading global entertainment and media conglomerate with a strong brand portfolio and diversified revenue streams across media networks, parks, experiences, and studio entertainment. The business quality is medium due to its durable brand and intangible assets but recent earnings pressure with a 31.4% decline in earnings in the most recent quarter highlights …
Merck & Co., Inc. is a leading global healthcare company specializing in pharmaceuticals, vaccines, and animal health products. Its business quality is high, supported by a durable competitive moat anchored in the dominant global position of Keytruda in PD-1/PD-L1 oncology, a strong vaccines portfolio including Gardasil, and scale in R&D and manufacturing. The company benefits from a seasoned lea…
Accumulation Zones
| Metric |
DIS |
MRK |
| Zone Low |
$104.57 |
$75.11 |
| Zone High |
$118.52 |
$85.12 |
| In Buy Zone? |
Yes
|
No
|